Literature DB >> 10882346

Physiological aspects of low-density lipoprotein oxidation.

M J Thomas1.   

Abstract

The oxidation of LDL is thought to be a major contributor to the development of atherosclerosis. Considerable descriptive evidence has been accumulated showing that oxidized LDL promotes pro-atherogenic events. However, direct evidence that oxidized LDL causes atherosclerosis is lacking. This article summarizes the results of recent studies that demonstrate how oxidized LDL affects cellular function, and highlights key issues that should be addressed to link LDL oxidation with atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882346     DOI: 10.1097/00041433-200006000-00011

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  5 in total

Review 1.  Vitamin E-stabilized UHMWPE for total joint implants: a review.

Authors:  Pierangiola Bracco; Ebru Oral
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

2.  Effect of bicarbonate on iron-mediated oxidation of low-density lipoprotein.

Authors:  Hirofumi Arai; Barbara S Berlett; P Boon Chock; Earl R Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-18       Impact factor: 11.205

Review 3.  Lipid metabolism, apoptosis and cancer therapy.

Authors:  Chunfa Huang; Carl Freter
Journal:  Int J Mol Sci       Date:  2015-01-02       Impact factor: 5.923

4.  Increasing Oxidative Stress with Progressive Hyperlipidemia in Human: Relation between Malondialdehyde and Atherogenic Index.

Authors:  Rui-Li Yang; Yong-Hui Shi; Gang Hao; Wu Li; Guo-Wei Le
Journal:  J Clin Biochem Nutr       Date:  2008-10-31       Impact factor: 3.114

5.  Antihypercholesterolemic and Antioxidative Potential of an Extract of the Plant, Piper betle, and Its Active Constituent, Eugenol, in Triton WR-1339-Induced Hypercholesterolemia in Experimental Rats.

Authors:  Karuppasamy Venkadeswaran; Arumugam Ramachandran Muralidharan; Thangaraj Annadurai; Vasanthakumar Vasantha Ruban; Mahalingam Sundararajan; Ramalingam Anandhi; Philip A Thomas; Pitchairaj Geraldine
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-09       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.